These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5808493)

  • 21. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein.
    Hiraoka H; Yamashita S; Matsuzawa Y; Kubo M; Nozaki S; Sakai N; Hirano K; Kawata S; Tarui S
    Hepatology; 1993 Jul; 18(1):103-10. PubMed ID: 8325601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New weapon for primary biliary cirrhosis from Japan.
    Zeniya M
    J Gastroenterol; 2003; 38(6):619-20. PubMed ID: 12858848
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs.
    Packard CJ
    Diabetes Nutr Metab; 1999 Oct; 12(5):311-5. PubMed ID: 10741344
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities in the treatment of primary biliary cirrhosis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Jun; 146(23):1245-9. PubMed ID: 15988919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation.
    Nikkilä K; Miettinen TA; Höckerstedt KV; Isoniemi H
    Transpl Int; 2005 Feb; 18(2):221-5. PubMed ID: 15691276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel treatment for refractory primary biliary cirrhosis?
    Miyaguchi S; Ebinuma H; Imaeda H; Nitta Y; Watanabe T; Saito H; Ishii H
    Hepatogastroenterology; 2000; 47(36):1518-21. PubMed ID: 11148991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense apolipoprotein B therapy: where do we stand?
    Akdim F; Stroes ES; Kastelein JJ
    Curr Opin Lipidol; 2007 Aug; 18(4):397-400. PubMed ID: 17620855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Bracaglia D; Cordova C
    Clin Ter; 1994 Jan; 144(1):3-9. PubMed ID: 8168349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate treatment in patients with primary biliary cirrhosis.
    Ohira H; Sato Y; Ueno T; Sata M
    Am J Gastroenterol; 2002 Aug; 97(8):2147-9. PubMed ID: 12190200
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
    Wolfhagen FH; van Buuren HR; Schalm SW
    Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On setting up control groups in biochemical studies].
    Levin VI; Danilov IP; Iarmakovich DF; Oshmianko SF
    Lab Delo; 1969; 1():35-7. PubMed ID: 4185355
    [No Abstract]   [Full Text] [Related]  

  • 35. [Allosteric regulation and models of receptors].
    Hanc O
    Cesk Farm; 1975 Dec; 24(10):437-40. PubMed ID: 1220876
    [No Abstract]   [Full Text] [Related]  

  • 36. [Utopic thinking in biochemistry and medicine].
    Wacker A
    Wien Med Wochenschr; 1971 Oct; 121(43):751-8. PubMed ID: 5156861
    [No Abstract]   [Full Text] [Related]  

  • 37. [CHOLESTEROLEMIC VARIATIONS IN HEPATOBILIARY PATIENTS].
    BUITRONCANAMERO MJ
    Clin Lab (Zaragoza); 1964 May; 77():357-71. PubMed ID: 14158284
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-permeable collodion membranes.
    BANASZAK LJ; McDONALD HJ
    Biochim Biophys Acta; 1961 Oct; 53():404-7. PubMed ID: 13864575
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of biochemistry in drug design.
    Witkop B
    Am Sci; 1967 Jun; 55(2):109-28. PubMed ID: 4859894
    [No Abstract]   [Full Text] [Related]  

  • 40. [Branched chains in biology].
    FERNANDEZ O
    An R Acad Nac Med (Madr); 1954; 71(3):383-92. PubMed ID: 13218317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.